American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.
about
Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race.DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival.Cancer Treatment-Induced Bone Loss in women with breast cancerCYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8.Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI SwitchAdherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.Adjuvant Aromatase Inhibitors in Early Breast Cancer May Not Increase the Risk of Falls.Early cardiac perfusion defects after left-sided radiation therapy for breast cancer: is there a volume response?Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative.Prevalence and Determinants of Adherence to Oral Adjuvant Endocrine Therapy among Breast Cancer Patients in Singapore.Adjuvant endocrine monotherapy for postmenopausal early breast cancer patients with hormone-receptor positive: a systemic review and network meta-analysis.Randomized Controlled Trial of a Home-Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors.Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in DenmarkGenomic Testing in the Management of Early-Stage Breast CancerPost-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recoveryAssociation of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole TherapyAdjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time
P2860
Q34379556-175CDADB-6214-4E19-A3C3-C7CFC4A6D091Q35103519-749E87D3-01CF-4565-B18E-00E80D300A6AQ35632616-7F8D7A2B-3277-4577-B119-815CB3AF67FAQ36545056-62D14C5F-F6C1-46ED-B312-909FE7B294A3Q36586900-C2A32BF7-9099-49FB-8551-0B7F0FC86EBEQ36713559-A392A75D-11D0-432B-A359-704B7E68714DQ37282924-D2F3C632-E00F-442A-9AA1-1A26DB2C4E6AQ38821679-DBBA2127-1AEF-4970-A23C-642C195CBC0EQ40519548-A5BFFD41-1CFF-4387-87F9-9108273C8BE3Q42131354-75743AE7-F875-4B66-888A-AD3CE322EC49Q47100249-961588F2-88AE-4EB5-97A4-FE27224DFE09Q53781768-A498D741-5CAC-4893-9587-1FA475B500BAQ57108405-9477B21F-52B2-40A3-AB9F-B4346969A9E9Q57117421-F4773F80-822F-4456-AB5F-7BA1CAD28A7BQ57301014-0BE7B1EA-5EFB-4BEE-AD45-D49BD85B8C5FQ58730332-3F50FC29-1264-4848-AAEE-7FD01855E1B4Q59243931-27049BFA-46A3-433A-86A9-3AD4AC3E35D6
P2860
American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
American society of clinical o ...... ceptor-positive breast cancer.
@ast
American society of clinical o ...... ceptor-positive breast cancer.
@en
American society of clinical o ...... ceptor-positive breast cancer.
@nl
type
label
American society of clinical o ...... ceptor-positive breast cancer.
@ast
American society of clinical o ...... ceptor-positive breast cancer.
@en
American society of clinical o ...... ceptor-positive breast cancer.
@nl
prefLabel
American society of clinical o ...... ceptor-positive breast cancer.
@ast
American society of clinical o ...... ceptor-positive breast cancer.
@en
American society of clinical o ...... ceptor-positive breast cancer.
@nl
P2093
P356
P1476
American society of clinical o ...... ceptor-positive breast cancer.
@en
P2093
Ann A Prestrud
Harold J Burstein
Jennifer J Griggs
Sarah Temin
P304
P356
10.1200/JOP.000082
P407
P577
2010-08-06T00:00:00Z